Legal & General Group’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.43M Sell
602,707
-60,655
-9% -$957K ﹤0.01% 1463
2025
Q4
$12.1M Sell
663,362
-30,782
-4% -$519K ﹤0.01% 1067
2025
Q3
$10.2M Sell
694,144
-19,432
-3% -$333K ﹤0.01% 1205
2025
Q2
$13M Buy
713,576
+37,699
+6% +$769K ﹤0.01% 1056
2025
Q1
$13.4M Sell
675,877
-160,973
-19% -$2.78M ﹤0.01% 980
2024
Q4
$14.4M Buy
836,850
+164,013
+24% +$3.09M ﹤0.01% 973
2024
Q3
$13.5M Buy
672,837
+438,527
+187% +$6.82M ﹤0.01% 1017
2024
Q2
$2.62M Buy
234,310
+10,904
+5% +$91.5K ﹤0.01% 1824
2024
Q1
$1.47M Buy
223,406
+42,025
+23% +$230K ﹤0.01% 2049
2023
Q4
$820K Buy
181,381
+4,876
+3% +$18K ﹤0.01% 2269
2023
Q3
$632K Buy
176,505
+14,862
+9% +$57.2K ﹤0.01% 2343
2023
Q2
$596K Buy
161,643
+84,565
+110% +$313K ﹤0.01% 2402
2023
Q1
$255K Buy
77,078
+7,883
+11% +$27.3K ﹤0.01% 2497
2022
Q4
$268K Buy
69,195
+49,722
+255% +$153K ﹤0.01% 2500
2022
Q3
$47K Sell
19,473
-7,317
-27% -$17.6K ﹤0.01% 2984
2022
Q2
$53K Buy
+26,790
New +$52.7K ﹤0.01% 2995
2021
Q2
Sell
-7,063
Closed -$12K 3479
2021
Q1
$12K Hold
7,063
﹤0.01% 3319
2020
Q4
$14K Hold
7,063
﹤0.01% 3212
2020
Q3
$17K Sell
7,063
-3,397
-32% -$9.31K ﹤0.01% 3016
2020
Q2
$31K Hold
10,460
﹤0.01% 2876
2020
Q1
$30K Buy
10,460
+335
+3% +$1.16K ﹤0.01% 2757
2019
Q4
$41K Buy
10,125
+1,748
+21% +$7.62K ﹤0.01% 2887
2019
Q3
$37K Buy
8,377
+3,362
+67% +$14.1K ﹤0.01% 2863
2019
Q2
$19K Buy
5,015
+2,204
+78% +$9.73K ﹤0.01% 3206
2019
Q1
$11K Hold
2,811
﹤0.01% 3234
2018
Q4
$7K Hold
2,811
﹤0.01% 3301
2018
Q3
$17K Hold
2,811
﹤0.01% 3244
2018
Q2
$13K Buy
+2,811
New +$14K ﹤0.01% 3271

Other funds holding ADMA